中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
24期
11222-11225
,共4页
高金颖%陈忠云%李珊珊%谷洁%韩艳%刘岚
高金穎%陳忠雲%李珊珊%穀潔%韓豔%劉嵐
고금영%진충운%리산산%곡길%한염%류람
脑梗死%脂联素%性别因素
腦梗死%脂聯素%性彆因素
뇌경사%지련소%성별인소
Brain infarction%Adiponectin%Sex factors
目的:探讨急性脑梗死(ACI)及其亚型的血清脂联素水平变化,并探讨脂联素水平是否存在性别差异。方法采用病例-对照研究,纳入中国汉族ACI患者160例和80例非ACI对照,按TOAST分型对 ACI 进行分组。应用酶联免疫吸附法(ELISA)测定血清脂联素水平。结果(1)病例组中血清脂联素水平明显低于对照组[(5.88±1.91)mg/L vs.(7.56±2.19)mg/L],差异有统计学意义(P<0.01);(2)ACI 亚型不同,脂联素水平不同,大动脉粥样硬化性卒中(LAA)组水平最低,小动脉闭塞性卒中或腔隙性卒中(SAA)组居中,心源性栓塞(CE)组水平最高[(5.25±1.60)mg/L vs.(6.05±2.07)mg/L vs.(7.17±1.71)mg/L],两两比较,差异均有统计学意义(P<0.05);(3)在对照组中,男性血清脂联素水平显著低于女性血清脂联素水平[(7.01±2.09)mg/L vs.(8.22±2.15)mg/L],差异有统计学意义(P<0.01),在ACI组中,并未发现存在性别差异;(4)多因素Logistic回归分析显示,脂联素是ACI,尤其是LAA、SAA发生的保护因素。结论血清脂联素水平降低可能是ACI的一个危险因素;在ACI组中脂联素水平未发现性别差异;LAA血清脂联素水平较其他ACI亚型低。
目的:探討急性腦梗死(ACI)及其亞型的血清脂聯素水平變化,併探討脂聯素水平是否存在性彆差異。方法採用病例-對照研究,納入中國漢族ACI患者160例和80例非ACI對照,按TOAST分型對 ACI 進行分組。應用酶聯免疫吸附法(ELISA)測定血清脂聯素水平。結果(1)病例組中血清脂聯素水平明顯低于對照組[(5.88±1.91)mg/L vs.(7.56±2.19)mg/L],差異有統計學意義(P<0.01);(2)ACI 亞型不同,脂聯素水平不同,大動脈粥樣硬化性卒中(LAA)組水平最低,小動脈閉塞性卒中或腔隙性卒中(SAA)組居中,心源性栓塞(CE)組水平最高[(5.25±1.60)mg/L vs.(6.05±2.07)mg/L vs.(7.17±1.71)mg/L],兩兩比較,差異均有統計學意義(P<0.05);(3)在對照組中,男性血清脂聯素水平顯著低于女性血清脂聯素水平[(7.01±2.09)mg/L vs.(8.22±2.15)mg/L],差異有統計學意義(P<0.01),在ACI組中,併未髮現存在性彆差異;(4)多因素Logistic迴歸分析顯示,脂聯素是ACI,尤其是LAA、SAA髮生的保護因素。結論血清脂聯素水平降低可能是ACI的一箇危險因素;在ACI組中脂聯素水平未髮現性彆差異;LAA血清脂聯素水平較其他ACI亞型低。
목적:탐토급성뇌경사(ACI)급기아형적혈청지련소수평변화,병탐토지련소수평시부존재성별차이。방법채용병례-대조연구,납입중국한족ACI환자160례화80례비ACI대조,안TOAST분형대 ACI 진행분조。응용매련면역흡부법(ELISA)측정혈청지련소수평。결과(1)병례조중혈청지련소수평명현저우대조조[(5.88±1.91)mg/L vs.(7.56±2.19)mg/L],차이유통계학의의(P<0.01);(2)ACI 아형불동,지련소수평불동,대동맥죽양경화성졸중(LAA)조수평최저,소동맥폐새성졸중혹강극성졸중(SAA)조거중,심원성전새(CE)조수평최고[(5.25±1.60)mg/L vs.(6.05±2.07)mg/L vs.(7.17±1.71)mg/L],량량비교,차이균유통계학의의(P<0.05);(3)재대조조중,남성혈청지련소수평현저저우녀성혈청지련소수평[(7.01±2.09)mg/L vs.(8.22±2.15)mg/L],차이유통계학의의(P<0.01),재ACI조중,병미발현존재성별차이;(4)다인소Logistic회귀분석현시,지련소시ACI,우기시LAA、SAA발생적보호인소。결론혈청지련소수평강저가능시ACI적일개위험인소;재ACI조중지련소수평미발현성별차이;LAA혈청지련소수평교기타ACI아형저。
Objective To investigate the association of the serum levels of adiponectin in patients with acute cerebral infarction and its subtypes and whether there is gender difference in the serum levels of adiponectin. Methods A total of 160 patients with acute cerebral infarction and 80 control subjects were recruited in this case-control study. The serum adiponectin levels were measured by enzyme-linked immunosorbent assay(ELISA), patients with cerebral infarction were grouped according to TOAST types. Results (1) The serum adiponectin levels in patient group were significantly lower than those in control group, (5.88±1.91)mg/L vs. (7.56±2.19)mg/L;(2) The serum adiponectin levels were differed in diverse stroke subtypes, being lowest in large-artery atherosclerosis group, intermediate in small-artery occlusion group, and highest in cardioembolism group, (5.25±1.60)mg/L vs. (6.05±2.07)mg/L vs. (7.17±1.71)mg/L, significantly different were found between multiple comparisons(P<0.05);(3) The serum adiponectin levels of males were significantly lower than those of females (7.01±2.09)mg/L vs. (8.22±2.15)mg/L in control group (P<0.01), but no significant gender difference was found in the serum levels of adiponectin in acute cerebral infarction group; (4) Multivariate logistic regression analysis showed that adiponectin was the protective factor of acute cerebral infarction, especially for large-artery atherosclerosis and small-artery occlusion. Conclusions Decreased serum levels of adiponectin may be a risk factor for acute cerebral infarction. No significant gender difference was found in the serum levels of adiponectin in acute cerebral infarction group. The large-artery atherosclerosis group was significantly lower than in the other subtypes of acute cerebral infarction.